Fidelity’s Health Care Sector strategy, which includes Fidelity Select Health Care and Fidelity Advisor Health Care, has the ingredients it needs for long-term success.
Fidelity Advisor Health Care M FACTX
- NAV / 1-Day Return 58.33 / +1.43 %
- Total Assets 5.0 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.230%
- Distribution Fee Level Average
- Share Class Type Front Load
- Category Health
- Investment Style Large Growth
- Min. Initial Investment —
- Status Open
- TTM Yield —
- Turnover 47%
USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 10:12 PM GMT+0
Morningstar’s Analysis FACTX
Will FACTX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 55.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Boston Scientific Corp | 9.95 | 480.8 Mil | Healthcare |
Eli Lilly and Co | 8.02 | 387.4 Mil | Healthcare |
UnitedHealth Group Inc | 7.10 | 342.9 Mil | Healthcare |
Danaher Corp | 6.66 | 321.5 Mil | Healthcare |
Merck & Co Inc | 4.75 | 229.5 Mil | Healthcare |
Regeneron Pharmaceuticals Inc | 4.59 | 221.6 Mil | Healthcare |
Penumbra Inc | 4.10 | 198.0 Mil | Healthcare |
CVS Health Corp | 3.77 | 182.2 Mil | Healthcare |
The Cigna Group | 3.55 | 171.5 Mil | Healthcare |
Thermo Fisher Scientific Inc | 2.79 | 134.7 Mil | Healthcare |